Arq, Inc. Reports Record 2025 Financial Results; Major Impairment Charge Drives Net Loss

Key Highlights from the Report

• Record Revenue: Arq, Inc. generated approximately \$120 million in revenue for the full year 2025, marking the highest in its history, primarily driven by strong performance in its Powdered Activated Carbon (PAC) segment.
• Adjusted EBITDA Growth: Adjusted EBITDA reached \$13.2 million for 2025, a 26% year-over-year improvement compared to \$10.5 million in 2024, reflecting the company’s focus on increasing revenues and cost discipline, especially in SG&A.
• Significant Net Loss Due to Impairment: Despite operational improvements, Arq reported a net loss of \$52.6 million (\$1.27 per diluted share) for 2025, compared to a net loss of \$5.1 million (\$0.14 per share) in 2024. The substantial increase is primarily attributed to a large non-cash impairment charge of \$44.8 million on long-lived assets recognized during the year.
• Interest Expense Decline: Full-year interest expense dropped to \$2.4 million from \$3.3 million in 2024, owing to lower average interest rates on outstanding debt.
• Operational Focus: The company highlighted ongoing efforts to ramp up operations, diversify end markets (including the Corbin Wetcake product), and maintain relationships with key customers and suppliers.
• Balance Sheet Position: As of December 31, 2025, Arq had total stockholders’ equity of \$167.96 million, down from \$217.28 million in 2024, reflecting the impact of the impairment.
• Cash Flows: Net cash provided by financing activities was \$3.7 million, compared to \$42.7 million in 2024. Net cash used in investing activities was \$8.16 million, mainly for property, plant, and equipment.

Details and Analysis for Investors

Arq, Inc. delivered a year of operational progress in 2025, achieving its highest-ever revenue at approximately \$120 million, a performance underpinned by the strength in its PAC business. This growth translated into a notable 26% increase in Adjusted EBITDA, reaching \$13.2 million, demonstrating management’s ability to both grow the top line and control costs.

However, the year was overshadowed by a non-cash impairment charge of \$44.8 million related to long-lived assets. This charge dramatically widened the company’s net loss to \$52.6 million, compared to only \$5.1 million in the prior year. The loss equates to \$1.27 per diluted share, a figure that is likely to concern shareholders and may be materially price-sensitive.

It is important for investors to note that such a substantial impairment signals management has reassessed the value of certain assets, possibly due to market conditions, operational challenges, or changing strategic priorities. While this charge does not directly affect cash flows, it does impact the company’s book value and could alter future strategic choices.

On the cash flow front, the company generated positive financing cash flows of \$3.7 million, although this is a significant decrease from the \$42.7 million in 2024, which included proceeds from stock issuances. Cash used in investing was \$8.16 million, reflecting continued investment in operational assets.

The balance sheet saw a decrease in stockholders’ equity from \$217.3 million to \$168 million, primarily due to the impairment. However, the company did not issue new equity in 2025, unlike the prior year, which saw public and private offerings.

Price-Sensitive Issues for Shareholders:

• The impairment charge and resulting net loss could trigger negative sentiment and downward pressure on the share price.
• Record revenues and improving EBITDA margins provide some offset, suggesting underlying operational health in core segments.
• Management’s commentary about market conditions, cost controls, and future plans—especially around diversification and operational ramp-up—will be closely watched for indications of a turnaround or further challenges.

The company also included a standard cautionary statement regarding forward-looking statements, highlighting risks such as economic and regulatory uncertainty, market demand, litigation, and execution of business strategy.

Conclusion

For investors, the key takeaway is that while Arq, Inc. is demonstrating growth in its core business and improving operational profitability, the substantial impairment charge and resulting large net loss are critical and potentially price-moving events. Shareholders should monitor management’s next steps and commentary for further clarity on asset values, future capital allocation, and operational outlook.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with financial advisors before making investment decisions. All data is based on the company’s reported filings and is subject to change based on future disclosures or restatements.

View Arq, Inc. Historical chart here